Mohamed Issa joined Incyte in January 2025 as Executive Vice President and Head of U.S. Oncology. He has over 20 years of global leadership experience in pharmaceuticals, consumer healthcare and med-tech, with expertise spanning strategy, commercialization and business development. Before Incyte, Mohamed spent 13 years at Johnson & Johnson, where he held senior roles leading U.S. Immunology, Neuroscience and Oncology businesses. Earlier in his career, he was co-founder and CEO of a consumer healthcare company and held various roles in sales, brand management and strategy in bio-pharmaceuticals. Mohamed holds a Doctor of Pharmacy degree from St. John’s University and a Master of Business Administration (MBA) in finance and economics from New York University’s Stern School of Business.